Sponsored by

xCures

Please click on the above banner for more details

WEBSITECHANGES

You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.

Click HERE for details on RSS.

Displaying items 4226 to 4250 of about 5940

Previous 25

Website Changes

11/10/2006

Northwest Biotherapeutics Discusses Results From Clinical Trials In Brain Cancer At Two Conferences

11/10/2006

Newly identified biomarker detects and regulates spread of brain tumors

11/10/2006

Neurospheres Enriched in Cancer Stem-Like Cells Are Highly Effective in Eliciting a Dendritic Cell-Mediated Immune Response against Malignant Gliomas.

11/10/2006

Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study.

11/10/2006

Toxicity and efficacy of protracted low dose temozolomide for the treatment of low grade gliomas.

11/10/2006

Temozolomide treatment for newly diagnosed anaplastic oligodendrogliomas: a clinical efficacy trial.

11/10/2006

Commercial flight and patients with intracranial mass lesions: a caveat. Report of two cases.

11/10/2006

Long-term response of pituitary carcinoma to temozolomide. Report of two cases.

11/10/2006

AACR Science Policy Alert

10/31/2006

Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma.

10/30/2006

Added article: Treatments for Glioblastomas by Dr Marc Chamberlain

10/30/2006

Northwest Biotherapeutics Discusses Results From Clinical Trials in Brain Cancer at Two Conferences

10/30/2006

Mayo Clinic Cancer Center -- Harnessing the Measles Virus to Attack Cancer Seeking a Cure for Glioblastoma Multiforme, Other Deadly Cancers

10/26/2006

Reata Announces Receipt of Orphan Drug Status for RTA 744 in Treatment of Malignant Glioma

10/18/2006

Research Yields Clues to Radiation-Resistant Brain Cancer

10/17/2006

Have a Chance Walk for brain tumors.. NYC Oct 29, 2006

10/17/2006

Temozolomide 3 weeks on and 1 week off as first-line therapy for recurrent glioblastoma: phase II study from gruppo italiano cooperativo di neuro-oncologia (GICNO).

10/17/2006

A North American brain tumor consortium (NABTC 99-04) phase II trial of temozolomide plus thalidomide for recurrent glioblastoma multiforme.

10/17/2006

PLXDC1 (TEM7) is identified in a genome-wide expression screen of glioblastoma endothelium.

10/17/2006

Survival and quality of life after hypofractionated stereotactic radiotherapy for recurrent malignant glioma.

10/17/2006

Administration of temozolomide during and after radiotherapy for newly diagnosed high-grade gliomas excluding glioblastoma multiforme.

10/17/2006

Local intracerebral administration of O(6)-benzylguanine combined with systemic chemotherapy with temozolomide of a patient suffering from a recurrent glioblastoma.

10/17/2006

Phase II study of thalidomide and radiation in children with newly diagnosed brain stem gliomas and glioblastoma multiforme.

10/17/2006

Monitoring the effects of BCNU chemotherapy Wafers (Gliadel((R))) in glioblastoma multiforme with proton magnetic resonance spectroscopic imaging at 3.0 Tesla.

10/16/2006

Tug McGraw Foundation and Honorary Chairman Tim McGraw to Honor Those Who Make a Difference at Benefit in Philadelphia

Our privacy / cookie policy has changed.
Click HERE to read it!